Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1CNS 1Breast 1

Conditions

Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Docetaxel 7pembrolizumab 3Trastuzumab 3Radiotherapy 3Paclitaxel 3Fluorodeoxyglucose F18 3Erlotinib Hydrochloride 3Cisplatin 3Vorinostat 2Taxes 2SS1(dsFv)PE38 2Polymerase Chain Reaction 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Gene Expression Profiling 2Filgrastim 2Cetuximab 2Biopsy 2zanidatamab 1vandetanib 1trastuzumab deruxtecan 1tipifarnib 1tanespimycin 1talactoferrin alfa 1spartalizumab 1sargramostim 1pertuzumab 1neratinib 1larotrectinib 1fluoromisonidazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Salivary Gland Neoplasms × Hypericum extract LI 160 × Thoracic × Clear all
NCT00041171 2016-07-12

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Alliance for Clinical Trials in Oncology

Phase 3 Withdrawn
BreastCNSGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡